BAKU, Azerbaijan, December 11. On December 11,
the opening ceremony of the Bone Marrow Transplantation Unit was
held at Liv Bona Dea Hospital, Trend reports.


Vice-President of the Heydar Aliyev Foundation Leyla Aliyeva and
Minister of Health Teymur Musayev attended the ceremony.

Leyla Aliyeva first visited a young patient receiving treatment at
the hospital under the auspices of the Heydar Aliyev Foundation,
inquired about the child’s health, and presented a gift.


The Bone Marrow Transplantation Unit was then officially
opened.


The new unit will perform bone marrow transplantations for both
adults and children. It was reported that the unit has six
specially isolated wards. This infrastructure allows for the
reception and treatment of up to 80 patients annually.


It was noted that the hospital also has an eight-bed haematology
department at patients’ disposal. All wards in the department are
equipped with a modern HEPA-filtered positive pressure system,
ensuring maximum protection for patients from infections.
Chemotherapy preparations are prepared in biosafety cabinets, and
cell collection is carried out in an independent apheresis
unit.


At the same time, the Blood Bank is capable of preparing
erythrocytes, platelets, plasma, and other components, including
obtaining granulocyte suspension. Irradiation and filtration
procedures are regularly applied to ensure the safety of transplant
patients.


The Bone Marrow Transplantation Unit was opened on the basis of
a license issued in accordance with the Decision of the Cabinet of
Ministers amending the “List of Specialized Medical Institutions
Performing Organ Transplantation,” approved by the Decision of the
Cabinet of Ministers dated 20 August 2021.


It is recalled that bone marrow and stem cell transplantation is
a modern and effective medical procedure used in the treatment of
various haematological and oncological diseases. Stem cells
obtained from the patient themselves (autologous) or from a donor
(allogeneic) are transplanted into the body after high-dose
chemotherapy. The aim is to replace diseased bone marrow with
healthy cells and restore blood formation.